Pharmaceutical

AAIC 2024: the evolution of Alzheimer’s clinical trials

Clinical trial trends point to studying combination therapies and lifestyle changes using alternate designs in Alzheimer’s research.

Jul 30, 2024 - 04:00
AAIC 2024: the evolution of Alzheimer’s clinical trials
Clinical trial trends point to studying combination therapies and lifestyle changes using alternate designs in Alzheimer’s research.
Read the original article

Tags:

Previous Article

Bold moves needed for California agriculture to adapt to climate change

Next Article

CHMP backs Boehringer’s Spevigo for preventing rare psoriasis flare-ups

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

PHIN-214 by PharmaIN for Portal Hypertension: Likelihood of Approval

PHIN-214 by PharmaIN for Portal Hypertension: Likelihoo...

Nov 4, 2023

CatalYm secures $150m to advance GDF-15-targeting immune modulator   

CatalYm secures $150m to advance GDF-15-targeting immun...

Jul 18, 2024

PF-07872412 by Pfizer for Streptococcal Pneumonia: Like...

Feb 20, 2024